Back
Enanta Pharmaceuticals, Inc. Stock Price Chart
Where Smart Money Buys Crypto (Hint: Not Coinbase)
Access Native Markets before the next 100x asset goes mainstream. Watch free training.
Sell
45
ENTA
Enanta Pharmaceuticals, Inc.
Last Price:
$14.41
Seasonality Move:
10.84%
7 Day Trial
ALL ACCESS PASS
$
7
BlackRock's $91B Secret
Learn how to access Native Markets before Coinbase. Watch the free training.-
The current trend is moderately bearish and ENTA is experiencing slight selling pressure.
Enanta Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.96 | Sell |
| 20-day SMA: | 15.03 | Buy |
| 50-day SMA: | 13.06 | Buy |
| 200-day SMA: | 8.74 | Buy |
| 8-day EMA: | 15.85 | Sell |
| 20-day EMA: | 15.07 | Buy |
| 50-day EMA: | 13.46 | Buy |
| 200-day EMA: | 10.31 | Buy |
Enanta Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.89 | Buy |
| Relative Strength Index (14 RSI): | 59.87 | Buy |
| Chaikin Money Flow: | -174612 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.87 - 15.73) | Buy |
| Bollinger Bands (100): | (8.4 - 13.78) | Buy |
Enanta Pharmaceuticals, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Enanta Pharmaceuticals, Inc. Stock
Is Enanta Pharmaceuticals, Inc. Stock a Buy?
-
Enanta Pharmaceuticals, Inc. share price is 15.77 while ENTA 8-day simple moving average is 15.96, which is a Sell signal.
-
The stock price of ENTA is 15.77 while Enanta Pharmaceuticals, Inc. 20-day SMA is 15.03, which makes it a Buy.
-
Enanta Pharmaceuticals, Inc. 50-day simple moving average is 13.06 while ENTA share price is 15.77, making it a Buy technically.
-
ENTA stock price is 15.77 and Enanta Pharmaceuticals, Inc. 200-day simple moving average is 8.74, creating a Buy signal.
ENTA Technical Analysis vs Fundamental Analysis
Sell
45
Enanta Pharmaceuticals, Inc. (ENTA)
is a Sell
Is Enanta Pharmaceuticals, Inc. a Buy or a Sell?
-
Enanta Pharmaceuticals, Inc. stock is rated a SellThe current Enanta Pharmaceuticals, Inc. [ENTA] share price is $15.77. The Score for ENTA is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Enanta Pharmaceuticals, Inc. Stock Info
Market Cap:
455.2M
Price in USD:
15.77
Share Volume:
480.2K
Enanta Pharmaceuticals, Inc. 52-Week Range
52-Week High:
17.15
52-Week Low:
4.09
Sell
45
Enanta Pharmaceuticals, Inc. (ENTA)
is a Sell
Enanta Pharmaceuticals, Inc. Share Price Forecast
-
What is the Enanta Pharmaceuticals, Inc. stock price today?The Enanta Pharmaceuticals, Inc. stock price is 15.77 USD today.
-
Will ENTA stock go up or go down?Enanta Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Enanta Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Enanta Pharmaceuticals, Inc. is overvalued.
Is Enanta Pharmaceuticals, Inc. Stock a Buy?
-
Enanta Pharmaceuticals, Inc. share price is 15.77 while ENTA 8-day exponential moving average is 15.85, which is a Sell signal.
-
The stock price of ENTA is 15.77 while Enanta Pharmaceuticals, Inc. 20-day EMA is 15.07, which makes it a Buy.
-
Enanta Pharmaceuticals, Inc. 50-day exponential moving average is 13.46 while ENTA share price is 15.77, making it a Buy technically.
-
ENTA stock price is 15.77 and Enanta Pharmaceuticals, Inc. 200-day simple moving average is 10.31, creating a Buy signal.
Fundamental Analysis of Enanta Pharmaceuticals, Inc.
Is Enanta Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and an increase next year of $0.56 per share.
Technical Analysis of Enanta Pharmaceuticals, Inc.
Should I short Enanta Pharmaceuticals, Inc. stock?
-
ENTA Moving Average Covergence Divergence (MACD) indicator is 0.89, suggesting Enanta Pharmaceuticals, Inc. is a Buy
-
Enanta Pharmaceuticals, Inc. Relative Strength Index (RSI) is 59.87, which suggest Enanta Pharmaceuticals, Inc. is overbought
-
The Bollinger Bands (25) for Enanta Pharmaceuticals, Inc. is (13.87 - 15.73), which suggest Enanta Pharmaceuticals, Inc. is a Buy
-
The Bollinger Bands (100) for Enanta Pharmaceuticals, Inc. is (8.4 - 13.78), which suggest Enanta Pharmaceuticals, Inc. is a Buy
* Enanta Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.